Yes, that could be great business, and Craig actually picked them out for mention in one of the webinars post CES.
Walgreens will be the surprise. Like you, I had always assumed retail. Another LTH pointed out the error of my ways.
Walgreens have over 9,000 stores around the USA and have access to 85% of the US population within 5 miles of a Walgreens store. Well, in June last year Walgreens setup a new Clinical Trial business :
Only last week Walgreens won their first major trial
By introducing CONNEQT PULSE to their tool set, Walgreens will be able to offer a set of metrics & services to their prospective customers to help them win more business .
Imagine this over the next couple of years:
Step 1 : Walgreens introduce CONNEQT Pulse to all stores for use in Clinical Trials - 9000 stores x 5 units per store.
Step 2 : Walgreens staff become advocates for CONNEQT PULSE over 12 - 18 months of successful use.
Step 3 : CardieX get CONNEQT PULSE re-designated as an OTC device
Step 4 : Walgreens range CONNEQT Pulse in all stores, with staff now familiar and advocates of the device.
Step 5 : CONNEQT PULSE quickly moves to a top seller in the blood pressure device section with 3 units sold per store per week
= 3 units x 9000 stores x 52 weeks x $160 = $225M USD sales per year
DYOR
IMO
Add to My Watchlist
What is My Watchlist?
